Company intelligence / Profile preview

Convergent Bioscience Ltd.

Toronto, Ontario, Canada

Ownership: Private
Employees: ~45
Development stage: Other

Overview

Convergent Bioscience Ltd. pioneered imaging capillary electrophoresis for protein charge heterogeneity characterization, a critical quality control tool for biologics production. Their products were considered a gold standard, with over 320 systems sold to more than 100 pharmaceutical and biotech companies globally. The company was acquired by Cell Biosciences in 2010 for approximately $12 million cash.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Convergent Bioscience Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convergent Bioscience Ltd..

Explore the full profile